Key result
Elevated systemic immune-inflammation index predicts pediatric fulminant myocarditis with an AUC of 0.76.
Why the study?
Myocarditis in children can lead to severe outcomes, and new systemic inflammatory indices have been proposed as prognostic markers but their predictive value in pediatric myocarditis is unclear.
Do systemic inflammatory indices (SII and SIRI) predict the development of fulminant myocarditis in pediatric patients?
Observational (n=122)
No
Do systemic inflammatory indices (SII and SIRI) predict the development of fulminant myocarditis in pediatric patients?
Systemic inflammatory indices such as SII and SIRI, calculated from routine blood parameters, may serve as early predictors of fulminant myocarditis in children.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for SII/SIRI in pediatric myocarditis prognostication; prospective validation needed before clinical use.
Background/Objectives: Myocarditis is a major cause of morbidity and mortality in children and can lead to long-term heart failure, dilated cardiomyopathy, the need for heart transplantation, or death. New systemic inflammatory indices that combine lymphocyte, neutrophil, and platelet counts have been recently used as strong prognostic markers of some inflammatory diseases and adverse outcomes of neoplasms. This study aimed to investigate the use of new systemic indices as early predictive markers for adverse outcomes in patients with pediatric myocarditis. Methods: This study retrospectively examined patients between the ages of >1 month and <18 years who were monitored in our clinic with a diagnosis of myocarditis between 1 January 2022 and 31 December 2024. The cases were divided into two groups: fulminant myocarditis (requiring the use of inotropes or extracorporeal membrane oxygenation due to hemodynamic disturbance) and non-fulminant myocarditis. The systemic inflammatory index values of these groups (calculated in the first 6 h) were compared, and the results were statistically analyzed. Results: The study included 122 pediatric myocarditis cases treated during the study period (80 boys; median age: 11 (IQR: 8–14) years). Twenty-six of these patients (21.3%) developed fulminant myocarditis. The median systemic immune-inflammation index (SII) value in the group with fulminant myocarditis was 1300 (IQR: 1000–1600), while this value was 500 (IQR: 350–650) for the non-fulminant group (p < 0.05). The median systemic inflammatory response index (SIRI) values were 2.9 (IQR: 2.5–3.2) in the fulminant myocarditis group and 1.5 (IQR: 1.2–1.8) in the non-fulminant group (p < 0.05). The cut-off values for fulminant myocarditis were found to be 1050 for the SII, with an AUC value of 0.76 (95% confidence interval: 0.80–0.96; p < 0.001), and 1.9 for the SIRI, with an AUC value of 0.64. Conclusions: The SII and SIRI may independently predict adverse myocarditis prognoses in children. These new biomarkers are easy to calculate using routine blood parameters.
No takes yet. Share an insight, caveat, or question.
Kangel et al. (2025) conducted an observational in Pediatric myocarditis (n=122). Systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) vs. Lower index values was evaluated on Fulminant myocarditis (AUC 0.76, 95% CI 0.80-0.96, p=<0.001). Systemic immune-inflammation index (SII) >1050 predicted fulminant myocarditis in children with an AUC of 0.76 (95% CI 0.80-0.96; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: